IACT Health has begun enrollment in two COVID-19 clinical trials in Columbus, Georgia. These are single visit studies requiring a single blood draw and nasal swab. These trials are out-patient trials for people who have tested positive for COVID-19.  IACT Health will be seeking up to 300 out-patient participants who have tested positive for COVID-19. Patients will receive a $50 gift card for participating. The goal of the trials is to learn more about how our bodies form immunities to the virus and at what point patients are no longer contagious. IACT Health has several more COVID-19 related clinical trials in the pipeline and hopes to be part of the cure.

"The world is racing to learn more about COVID-19 and the virus that creates it. This disease is causing illness and death in ways that we have never seen before. Research is need immediately so that we learn what is necessary to save lives, create cures for those who are infected, and prevent others from becoming infected. IACT Health is ready to begin all this research,” stated Dr. Jeffrey Kingsley, CEO of IACT Health.